News & Updates

There appears to be a sex-specific difference in the risk of colorectal cancer death after adenoma removal, with women being at higher risk than men, according to a study.

The introduction and use of chemoimmunotherapeutic agents such as rituximab, ofatumumab, and obinutuzumab has led to population-level improvements in survival from chronic lymphocytic leukaemia (CLL), a recent study has found.

Abnormal p53 immunohistochemical (IHC) findings may indicate a higher risk of progression in Barrett’s oesophagus (BE) patients, a new study has found.

Pheochromocytomas (PCC) and paragangliomas (PGL) show a wide range of symptoms, with frequent intraoperative instability despite good preoperative preparation, according to a Singapore study. In addition, up to one-fifth of the patients in a single centre developed disease recurrences and metastasis.

Reduced-dose treatment with androgen receptor pathway inhibitors (ARPI) lead to poorer oncological outcomes relative to full-dose regimens in castration-resistant prostate cancer (CRPC), a recent study has found.

Type 2 diabetes (T2D) patients exposed to hydrochlorothiazide for more than 2 years appear to be at higher risk of cutaneous squamous cell carcinoma (cSCC), as reported in a recent study.